Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cullinan Therapeutics, Inc. | Chief Legal Officer | Common Stock | 90.7K | $1.03M | $11.41 | Dec 18, 2024 | Direct |
GENOCEA BIOSCIENCES, INC. | CHIEF LEGAL & COMPLIANCE OFF | Common Stock | 43K | $53.8K | $1.25 | Jun 1, 2022 | Direct |
Cullinan Oncology, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 100K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CGEM | Cullinan Therapeutics, Inc. | Dec 18, 2024 | 1 | -$39.7K | 4 | Dec 20, 2024 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 23, 2024 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Dec 21, 2023 | 1 | -$11.9K | 4 | Dec 22, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Dec 18, 2023 | 1 | -$2.38K | 4 | Dec 20, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Jun 20, 2023 | 1 | -$3.77K | 4 | Jun 21, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | May 18, 2023 | 1 | -$2.55K | 4 | May 19, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Apr 18, 2023 | 1 | -$3.11K | 4 | Apr 20, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Mar 20, 2023 | 1 | -$3.45K | 4 | Mar 27, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Feb 17, 2023 | 2 | $0 | 4 | Feb 21, 2023 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Aug 15, 2022 | 1 | $0 | 4 | Aug 16, 2022 | Chief Legal Officer |
CGEM | Cullinan Oncology, Inc. | Aug 15, 2022 | 0 | $0 | 3 | Aug 16, 2022 | Chief Legal Officer |
GNCA | GENOCEA BIOSCIENCES, INC. | Jun 1, 2022 | 1 | -$150 | 4 | Jun 2, 2022 | CHIEF LEGAL & COMPLIANCE OFF |
GNCA | GENOCEA BIOSCIENCES, INC. | Mar 15, 2022 | 2 | $0 | 4 | Mar 17, 2022 | CHIEF LEGAL & COMPLIANCE OFF |